{"id":"https://openalex.org/W2958958151","doi":"https://doi.org/10.1096/fasebj.20.4.a241","title":"Novel small molecule antagonists of neuropeptide FF1 receptor as potential therapy for neuropathic pain","display_name":"Novel small molecule antagonists of neuropeptide FF1 receptor as potential therapy for neuropathic pain","publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2958958151","doi":"https://doi.org/10.1096/fasebj.20.4.a241","mag":"2958958151"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.20.4.a241","doi":"https://doi.org/10.1096/fasebj.20.4.a241","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.20.4.a241","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005645056","display_name":"Jelveh Lameh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jelveh Lameh","raw_affiliation_strings":["Biosciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007737574","display_name":"Luis R. Gardell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis R Gardell","raw_affiliation_strings":["Biosciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080893795","display_name":"Fabio Bertozzi","orcid":"https://orcid.org/0000-0001-7434-3688","observed_orcids":["https://orcid.org/0000-0001-7434-3688"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fabio Bertozzi","raw_affiliation_strings":["Medicinal Chemistry, ACADIA Pharmaceuticals, 3911 Sorrento Valley Blvd, San Diego, CA, 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, ACADIA Pharmaceuticals, 3911 Sorrento Valley Blvd, San Diego, CA, 92121","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086982879","display_name":"Derek Nguyen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Derek Nguyen","raw_affiliation_strings":["Biosciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020173627","display_name":"Abhishek Bajpai","orcid":"https://orcid.org/0000-0001-6230-6708","observed_orcids":["https://orcid.org/0000-0001-6230-6708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhishek Bajpai","raw_affiliation_strings":["Biosciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020206371","display_name":"Roger Olsson","orcid":"https://orcid.org/0000-0002-7107-3472","observed_orcids":["https://orcid.org/0000-0002-7107-3472"]},"institutions":[{"id":"https://openalex.org/I125377440","display_name":"Acadia Pharmaceuticals (United States)","ror":"https://ror.org/030bhbq32","country_code":"US","type":"company","lineage":["https://openalex.org/I125377440"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger Olsson","raw_affiliation_strings":["Medicinal Chemistry, ACADIA Pharmaceuticals, 3911 Sorrento Valley Blvd, San Diego, CA, 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, ACADIA Pharmaceuticals, 3911 Sorrento Valley Blvd, San Diego, CA, 92121","institution_ids":["https://openalex.org/I125377440"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070529034","display_name":"Douglas W. Bonhaus","orcid":"https://orcid.org/0000-0002-6567-2348","observed_orcids":["https://orcid.org/0000-0002-6567-2348"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas W Bonhaus","raw_affiliation_strings":["Biosciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosciences","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.29012724,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.548799991607666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.548799991607666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.447299987077713,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11204","display_name":"Ion Channels and Receptors","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2809","display_name":"Sensory Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuropeptide-ff","display_name":"neuropeptide FF","score":0.8199999928474426},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.9789999723434448},{"id":"https://openalex.org/keywords/spinal-nerve-ligation","display_name":"spinal nerve ligation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/tactile-hypersensitivity","display_name":"tactile hypersensitivity","score":0.9430000185966492},{"id":"https://openalex.org/keywords/small-molecule-antagonists","display_name":"small molecule antagonists","score":0.722000002861023},{"id":"https://openalex.org/keywords/endogenous-opioid-system","display_name":"endogenous opioid system","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6914944648742676},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.681751012802124},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6198344826698303},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4724957048892975},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.4294707477092743},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20246416330337524},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1867198944091797},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12326818704605103},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.05097898840904236}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.20.4.a241","doi":"https://doi.org/10.1096/fasebj.20.4.a241","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.20.4.a241","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315029","display_name":"ACADIA Pharmaceuticals","ror":"https://ror.org/030bhbq32"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2154159653","https://openalex.org/W2313904596","https://openalex.org/W3162341687","https://openalex.org/W7100464162","https://openalex.org/W2078974336","https://openalex.org/W2076250319","https://openalex.org/W3043402436","https://openalex.org/W2113887382","https://openalex.org/W2314787859","https://openalex.org/W4388022636"],"abstract_inverted_index":{"The":[0],"amidated":[1],"neuropeptide":[2],"FF":[3],"(NPFF)":[4],"was":[5],"originally":[6],"characterized":[7],"as":[8,116,178],"a":[9],"modulator":[10],"of":[11,72,85,113,143,155,171],"the":[12,25,69,83,92,106,111,156],"endogenous":[13],"opioid":[14],"system.":[15],"NPFF":[16,47],"and":[17,27,40,49,74,127,158],"its":[18],"related":[19],"peptides":[20],"are":[21,62,136],"widely":[22,63],"expressed":[23],"in":[24,34,65,122,138],"CNS":[26],"have":[28,51,57],"been":[29,52,78],"shown":[30,58],"to":[31,82],"be":[32,175],"involved":[33],"modulating":[35],"pain":[36],"sensitivity,":[37],"endocrine":[38],"functions,":[39],"food":[41],"intake.":[42],"Two":[43],"human":[44],"receptors":[45,61],"for":[46,88,105,181],"(FF1":[48],"FF2)":[50],"identified.":[53],"Ligand":[54],"binding":[55,128],"studies":[56],"that":[59,133,168],"both":[60],"distributed":[64],"brain.":[66],"To":[67],"date":[68],"specific":[70],"role":[71],"FF1":[73,107,119,145,172],"FF2":[75,121],"has":[76],"not":[77],"elucidated,":[79],"mainly":[80],"due":[81],"lack":[84],"selective":[86,98,144,169],"ligands":[87],"these":[89,114,134],"receptors.":[90],"In":[91],"present":[93],"investigation":[94],"we":[95,131],"highlight":[96],"several":[97],"non\u2010peptide":[99],"antagonists":[100,117,147,170],"from":[101],"different":[102],"structural":[103],"classes":[104],"receptor.":[108],"We":[109],"demonstrate":[110],"selectivity":[112],"compounds":[115,135],"at":[118],"over":[120],"vitro":[123],"using":[124],"RSAT,":[125],"cAMP":[126],"assays.":[129],"Moreover,":[130],"show":[132],"active":[137],"vivo":[139],".":[140],"Systemic":[141],"administration":[142],"receptor":[146,173],"dose\u2010dependently":[148],"alleviated":[149],"tactile":[150],"hypersensitivity":[151],"induced":[152],"by":[153,185],"ligation":[154],"L5":[157],"L6":[159],"spinal":[160],"nerves":[161],"(aka,":[162],"Chung":[163],"model).":[164],"These":[165],"data":[166],"suggest":[167],"should":[174],"further":[176],"explored":[177],"novel":[179],"treatments":[180],"neuropathic":[182],"pain.":[183],"[Supported":[184],"ACADIA":[186],"Pharmaceuticals]":[187]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-23T00:00:00"}